Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 9, 2004

Book review

Favourites:
ADD

Review article

Favourites:
ADD

Heparins and Heparinoids: Occurrence, Structure and Mechanism of Antithrombotic and Hemorrhagic Activities
pp. 951-966(16)
Authors: Nader, Helena B.; Lopes, Carla C.; Rocha, Hugo A.O.; Santos, Elizeu A.; Dietrich, Carl P.

Favourites:
ADD
Favourites:
ADD

Biochemical and Pharmacologic Heterogeneity in Low Molecular Weight Heparins. Impact on the Therapeutic Profile
pp. 983-999(17)
Authors: Fareed, Jawed; Hoppensteadt, Debra; Schultz, Christopher; Ma, Qing; Kujawski, Michelle F.; Messmore, Harry

Favourites:
ADD

Studies Comparing Low Molecular Weight Heparin with Heparin for the Treatment of Thromboembolism: A Literature Review
pp. 1001-1010(10)
Authors: Messmore, H. L.; Coyne, E.; Wehrmacher, W. H.; Demir, A. M.; Fareed, J.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

An Overall Picture of Chemokine Receptors: Basic Research and Drug Development
pp. 1045-1055(11)
Authors: Chen, Li; Pei, Gang; Zhang, Wenbo

Favourites:
ADD

Simulating the Interactions of Toxins with K+ Channels
pp. 1057-1067(11)
Authors: Huang, Xiaoqin; Liu, Hong; Cui, Meng; Fu, Wei; Yu, Kunqian; Chen, Kaixian; Luo, Xiaomin; Shen, Jianhua; Jiang, Hualiang

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content